{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:23:30Z","timestamp":1774538610344,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T00:00:00Z","timestamp":1676419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>T cells have been implicated in the development and progression of inflammatory processes in chronic heart failure (CHF). Cardiac resynchronization therapy (CRT) has beneficial effects on symptoms and cardiac remodeling in CHF. However, its impact on the inflammatory immune response remains controversial. We aimed to study the impact of CRT on T cells in heart failure (HF) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-nine HF patients were evaluated before CRT (T0) and six months later (T6). Quantification of T cells, their subsets, and their functional characterization, after in vitro stimulation, were evaluated by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      T regulatory (Treg) cells were decreased in CHF patients (healthy group (HG): 1.08\u2009\u00b1\u20090.50\n                      <jats:italic>versus<\/jats:italic>\n                      (heart failure patients (HFP)-T0: 0.69\u2009\u00b1\u20090.40,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022) and remaining diminished after CRT (HFP-T6: 0.61\u2009\u00b1\u20090.29,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). Responders (R) to CRT presented a higher frequency of T cytotoxic (Tc) cells producing IL-2 at T0 compared with non-responders (NR) (R: 36.52\u2009\u00b1\u200912.55\n                      <jats:italic>versus<\/jats:italic>\n                      NR: 24.71\u2009\u00b1\u200911.66,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006). After CRT, HF patients presented a higher percentage of Tc cells expressing TNF-\u03b1 and IFN-\u03b3 (HG: 44.50\u2009\u00b1\u200916.62\n                      <jats:italic>versus<\/jats:italic>\n                      R: 61.47\u2009\u00b1\u200920.54,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014; and HG: 40.62\u2009\u00b1\u200915.36\n                      <jats:italic>versus<\/jats:italic>\n                      R: 52.39\u2009\u00b1\u200918.66,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.049, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The dynamic of different functional T cell subpopulations is significantly altered in CHF, which results in an exacerbated pro-inflammatory response. Even after CRT, it seems that the inflammatory condition underlying CHF continues to evolve with the progression of the disease. This could be due, at least in part, to the inability to restore Treg cells levels.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : Observational and prospective study with no trial registration.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03109-x","type":"journal-article","created":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:04:57Z","timestamp":1676459097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Reduced numbers of regulatory T cells in chronic heart failure seems not to be restored by cardiac resynchronization therapy"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0571-0250","authenticated-orcid":false,"given":"S\u00edlvia","family":"Martins","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3103-4353","authenticated-orcid":false,"given":"Nat\u00e1lia","family":"Ant\u00f3nio","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2288","authenticated-orcid":false,"given":"Tiago","family":"Carvalheiro","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1136-6118","authenticated-orcid":false,"given":"Paula","family":"Laranjeira","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Rodrigues","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9255-3064","authenticated-orcid":false,"given":"Lino","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0927-2331","authenticated-orcid":false,"given":"C\u00e2ndida","family":"Tomaz","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6562-5859","authenticated-orcid":false,"given":"Artur","family":"Paiva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,2,15]]},"reference":[{"issue":"10","key":"3109_CR1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM200309043491019","volume":"349","author":"M Jessup","year":"2003","unstructured":"Jessup M, Brozena S. Heart failure-reply. N Engl J Med. 2003;349(10):1004\u20131004.","journal-title":"N Engl J Med"},{"issue":"4","key":"3109_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.5114\/aoms.2014.47878","volume":"11","author":"E Straburzynska-Migaj","year":"2015","unstructured":"Straburzynska-Migaj E, Kaluzna-Oleksy M, Maggioni AP, Grajek S, Opolski G, Ponikowski P, et al. Patients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot)-Polish population. Arch Med Sci. 2015;11(4):743\u201350.","journal-title":"Arch Med Sci"},{"issue":"2","key":"3109_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurjhf\/hfn043","volume":"11","author":"S Heymans","year":"2009","unstructured":"Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand JL, Cohen-Tervaert JW, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11(2):119\u201329.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"3109_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.clinbiochem.2012.11.002","volume":"46","author":"AE Stanciu","year":"2013","unstructured":"Stanciu AE, Vatasescu RG, Stanciu MM, Iorgulescu C, Vasile AI, Dorobantu M. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects. Clin Biochem. 2013;46(3):230\u20134.","journal-title":"Clin Biochem"},{"issue":"1","key":"3109_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"T-T Tang","year":"2012","unstructured":"Tang T-T, Yuan J, Zhu Z-F, Zhang W-C, Xiao H, Xia N, et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res Cardiol. 2012;107(1):1\u201317.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"3109_CR6","doi-asserted-by":"publisher","first-page":"H124","DOI":"10.1152\/ajpheart.00028.2019","volume":"317","author":"RM Blanton","year":"2019","unstructured":"Blanton RM, Carrillo-Salinas FJ, Alcaide P. T-cell recruitment to the heart: friendly guests or unwelcome visitors? Am J Physiol Heart Circ Physiol. 2019;317(1):H124\u201340.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"3109_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0008-6363(02)00238-9","volume":"54","author":"A Yndestad","year":"2002","unstructured":"Yndestad A, Kristian Dam\u00e5s J, Geir Eiken H, Holm T, Haug T, Simonsen S, Fr\u00f8land SS, Gullestad L, Aukrust P. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res. 2002;54(1):175\u201382.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"3109_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0008-6363(03)00362-6","volume":"60","author":"A Yndestad","year":"2003","unstructured":"Yndestad A. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res. 2003;60(1):141\u20136.","journal-title":"Cardiovasc Res"},{"issue":"23\u201324","key":"3109_CR9","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.cca.2010.08.013","volume":"411","author":"N Li","year":"2010","unstructured":"Li N, Bian H, Zhang J, Li X, Ji X, Zhang Y. The Th17\/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clin Chim Acta. 2010;411(23\u201324):1963\u20138.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"3109_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.amjcard.2007.03.052","volume":"100","author":"T Fukunaga","year":"2007","unstructured":"Fukunaga T, Soejima H, Irie A, Sugamura K, Oe Y, Tanaka T, et al. Relation between CD4+ T-cell activation and severity of chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 2007;100(3):483\u20138.","journal-title":"Am J Cardiol"},{"issue":"48","key":"3109_CR11","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1093\/eurheartj\/ehz516","volume":"40","author":"TT Tang","year":"2019","unstructured":"Tang TT, Zhu YC, Dong NG, Zhang S, Cai J, Zhang LX, et al. Pathologic T-cell response in ischaemic failing hearts elucidated by T-cell receptor sequencing and phenotypic characterization. Eur Heart J. 2019;40(48):3924\u201333.","journal-title":"Eur Heart J"},{"issue":"7","key":"3109_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.apjtm.2016.05.006","volume":"9","author":"YH Cai","year":"2016","unstructured":"Cai YH, Ma ZJ, Lu XY, He EL, You MY. Study on the effect and mechanism of the dysfunction of CD4(+) T cells in the disease process of chronic cardiac failure. Asian Pac J Trop Med. 2016;9(7):682\u20137.","journal-title":"Asian Pac J Trop Med"},{"issue":"2","key":"3109_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1161\/CIRCULATIONAHA.118.036065","volume":"139","author":"SS Bansal","year":"2019","unstructured":"Bansal SS, Ismahil MA, Goel M, Zhou G, Rokosh G, Hamid T, Prabhu SD. Dysfunctional and proinflammatory regulatory T-lymphocytes are essential for adverse cardiac remodeling in ischemic cardiomyopathy. Circulation. 2019;139(2):206\u201321.","journal-title":"Circulation"},{"issue":"1","key":"3109_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1054\/jcaf.2002.31628","volume":"8","author":"M Yamaoka-Tojo","year":"2002","unstructured":"Yamaoka-Tojo M, Tojo T, Inomata T, Machida Y, Osada K, Izumi T. Circulating levels of interleukin 18 reflect etiologies of heart failure: Th1\/Th2 cytokine imbalance exaggerates the pathophysiology of advanced heart failure. J Card Fail. 2002;8(1):21\u20137.","journal-title":"J Card Fail"},{"key":"3109_CR15","doi-asserted-by":"publisher","first-page":"732794","DOI":"10.3389\/fimmu.2021.732794","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu Y, Xia N, Cheng X. Regulatory T cells in chronic heart failure. Front Immunol. 2021;12:732794.","journal-title":"Front Immunol"},{"issue":"1","key":"3109_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21737-9","volume":"12","author":"I Santos-Zas","year":"2021","unstructured":"Santos-Zas I, Lemari\u00e9 J, Zlatanova I, Cachanado M, Seghezzi J-C, Benamer H, et al. Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling. Nat Commun. 2021;12(1):1\u201313.","journal-title":"Nat Commun"},{"issue":"2","key":"3109_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.repc.2017.06.017","volume":"37","author":"L Almeida-Morais","year":"2018","unstructured":"Almeida-Morais L, Abreu A, Oliveira M, Silva Cunha P, Rodrigues I, Portugal G, et al. Impact of cardiac resynchronization therapy on inflammatory biomarkers and cardiac remodeling: the paradox of functional and echocardiographic response. Rev Port Cardiol (Engl Ed). 2018;37(2):105\u201313.","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"5","key":"3109_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.5114\/aoms.2016.58635","volume":"13","author":"K Ptaszynska-Kopczynska","year":"2017","unstructured":"Ptaszynska-Kopczynska K, Szpakowicz A, Marcinkiewicz-Siemion M, Lisowska A, Waszkiewicz E, Witkowski M, et al. Interleukin-6 signaling in patients with chronic heart failure treated with cardiac resynchronization therapy. Arch Med Sci. 2017;13(5):1069\u201377.","journal-title":"Arch Med Sci"},{"issue":"3","key":"3109_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000346621","volume":"124","author":"P Osmancik","year":"2013","unstructured":"Osmancik P, Herman D, Stros P, Linkova H, Vondrak K, Paskova E. Changes and prognostic impact of apoptotic and inflammatory cytokines in patients treated with cardiac resynchronization therapy. Cardiology. 2013;124(3):190\u20138.","journal-title":"Cardiology"},{"key":"3109_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3352\/jeehp.2021.18.17","volume":"18","author":"H Kang","year":"2021","unstructured":"Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021;18:17.","journal-title":"J Educ Eval Health Prof"},{"key":"3109_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4065\/mcp.2009.0494","volume":"5","author":"GV Ramani","year":"2010","unstructured":"Ramani GV, Uber PA, Mehra MR. Chronic heart failure: contemporary diagnosis and management. Mayo Clin Proc. 2010;5:180\u201395.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"3109_CR22","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1089\/ars.2009.2488","volume":"11","author":"MN Jameel","year":"2009","unstructured":"Jameel MN, Zhang J. Heart failure management: the present and the future. Antioxid Redox Signal. 2009;11(8):1989\u20132010.","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"3109_CR23","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10840-018-0491-3","volume":"54","author":"S Martins","year":"2019","unstructured":"Martins S, Carvalheiro T, Laranjeira P, Martinho A, Elvas L, Gon\u00e7alves L, Tomaz C, Ant\u00f3nio N, Paiva A. Impact of cardiac resynchronization therapy on circulating IL-17 producing cells in patients with advanced heart failure. J Interv Card Electrophysiol. 2019;54(3):257\u201365.","journal-title":"J Interv Card Electrophysiol"},{"issue":"6917","key":"3109_CR24","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860\u20137.","journal-title":"Nature"},{"key":"3109_CR25","doi-asserted-by":"crossref","unstructured":"McComb S, Thiriot A, Akache B, Krishnan L, Stark F: Introduction to the immune system. In: Immunoproteomics. Springer; 2019; 1\u201324.","DOI":"10.1007\/978-1-4939-9597-4_1"},{"issue":"4","key":"3109_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/MAJ.0000000000000544","volume":"350","author":"KJ Choi","year":"2015","unstructured":"Choi KJ, Tsomidou C, Lerakis S, Madanieh R, Vittorio TJ, Kosmas CE. Lipid interventions in aortic valvular disease. Am J Med Sci. 2015;350(4):313\u20139.","journal-title":"Am J Med Sci"},{"key":"3109_CR27","first-page":"1","volume":"5","author":"LM Wienecke","year":"2021","unstructured":"Wienecke LM, Cohen S, Bauersachs J, Mebazaa A, Chousterman BG. Immunity and inflammation: the neglected key players in congenital heart disease? Heart Fail Rev. 2021;5:1\u201315.","journal-title":"Heart Fail Rev"},{"issue":"1","key":"3109_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/16078454.2019.1687144","volume":"24","author":"D Borgel","year":"2019","unstructured":"Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F. Inflammation in deep vein thrombosis: a therapeutic target? Hematology. 2019;24(1):742\u201350.","journal-title":"Hematology"},{"issue":"03","key":"3109_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0031-1278255","volume":"16","author":"M Montagnana","year":"2007","unstructured":"Montagnana M, Fava C, Arosio E, Degan M, Tommasoli RM, De Marchi S, et al. Inflammation and platelet activation in peripheral arterial occlusive disease. Int J Angiol. 2007;16(03):84\u20138.","journal-title":"Int J Angiol"},{"issue":"2","key":"3109_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","volume":"57","author":"DG Harrison","year":"2011","unstructured":"Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension. 2011;57(2):132\u201340.","journal-title":"Hypertension"},{"issue":"9952","key":"3109_CR31","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0140-6736(14)60687-5","volume":"384","author":"JM Lord","year":"2014","unstructured":"Lord JM, Midwinter MJ, Chen Y-F, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, Lilford RJ. The systemic immune response to trauma: an overview of pathophysiology and treatment. The Lancet. 2014;384(9952):1455\u201365.","journal-title":"The Lancet"},{"issue":"1","key":"3109_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1213\/ANE.0000000000005095","volume":"132","author":"RP Dutton","year":"2021","unstructured":"Dutton RP. Inflammation after surgical trauma: bleeding or clotting? Anesth Analg. 2021;132(1):80\u20131.","journal-title":"Anesth Analg"},{"issue":"3","key":"3109_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.tracli.2015.03.005","volume":"22","author":"O Garraud","year":"2015","unstructured":"Garraud O, Hamzeh-Cognasse H, Laradi S, Pozzetto B, Cognasse F. Blood transfusion and inflammation as of yesterday, today and tomorrow. Transfus Clin Biol. 2015;22(3):168\u201377.","journal-title":"Transfus Clin Biol"},{"issue":"3","key":"3109_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/j.arrt.2003.08.008","volume":"10","author":"K Kalantar-Zadeh","year":"2003","unstructured":"Kalantar-Zadeh K, Stenvinkel P, Pillon L, Kopple JD. Inflammation and nutrition in renal insufficiency. Adv Ren Replace Ther. 2003;10(3):155\u201369.","journal-title":"Adv Ren Replace Ther"},{"issue":"1","key":"3109_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40\u201350.","journal-title":"Blood"},{"key":"3109_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.thromres.2016.02.022","volume":"141","author":"CM Larkin","year":"2016","unstructured":"Larkin CM, Santos-Martinez M-J, Ryan T, Radomski MW. Sepsis-associated thrombocytopenia. Thromb Res. 2016;141:11\u20136.","journal-title":"Thromb Res"},{"issue":"6","key":"3109_CR37","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1530\/REP-16-0453","volume":"152","author":"M Nadeau-Vall\u00e9e","year":"2016","unstructured":"Nadeau-Vall\u00e9e M, Obari D, Palacios J, Brien M-\u00c8, Duval C, Chemtob S, Girard S. Sterile inflammation and pregnancy complications: a review. Reproduction. 2016;152(6):R277\u201392.","journal-title":"Reproduction"},{"issue":"5","key":"3109_CR38","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1540-8191.2007.00447.x","volume":"22","author":"SG Raja","year":"2007","unstructured":"Raja SG, Berg GA. Impact of off-pump coronary artery bypass surgery on systemic inflammation: current best available evidence. J Card Surg. 2007;22(5):445\u201355.","journal-title":"J Card Surg"},{"key":"3109_CR39","first-page":"20","volume":"2","author":"H Wang","year":"2020","unstructured":"Wang H, Liu Z, Shao J, Lin L, Jiang M, Wang L, et al. Immune and inflammation in acute coronary syndrome: molecular mechanisms and therapeutic implications. J Immunol Res. 2020;2:20.","journal-title":"J Immunol Res"},{"issue":"1","key":"3109_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-020-01713-8","volume":"11","author":"G Crist\u00f3v\u00e3o","year":"2020","unstructured":"Crist\u00f3v\u00e3o G, Milner J, Sousa P, Ventura M, Crist\u00f3v\u00e3o J, Elvas L, et al. Improvement in circulating endothelial progenitor cells pool after cardiac resynchronization therapy: increasing the list of benefits. Stem Cell Res Ther. 2020;11(1):1\u20138.","journal-title":"Stem Cell Res Ther"},{"issue":"11","key":"3109_CR41","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/ejhf.167","volume":"16","author":"AC Kydd","year":"2014","unstructured":"Kydd AC, Khan FZ, Ring L, Pugh PJ, Virdee MS, Dutka DP. Development of a multiparametric score to predict left ventricular remodelling and prognosis after cardiac resynchronization therapy. Eur J Heart Fail. 2014;16(11):1206\u201313.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"3109_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12265-012-9365-8","volume":"5","author":"T Carvalheiro","year":"2012","unstructured":"Carvalheiro T, Velada I, Valado A, Mendes F, Martinho A, Antonio N, et al. Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction. J Cardiovasc Transl Res. 2012;5(3):309\u201320.","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"3109_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cellimm.2010.05.004","volume":"264","author":"A Henriques","year":"2010","unstructured":"Henriques A, Ines L, Couto M, Pedreiro S, Santos C, Magalhaes M, et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in systemic lupus erythematosus. Cell Immunol. 2010;264(1):97\u2013103.","journal-title":"Cell Immunol"},{"issue":"12","key":"3109_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.it.2006.10.002","volume":"27","author":"AH Banham","year":"2006","unstructured":"Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Trends Immunol. 2006;27(12):541\u20134.","journal-title":"Trends Immunol"},{"issue":"1","key":"3109_CR45","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1213\/ANE.0000000000002636","volume":"126","author":"TR Vetter","year":"2018","unstructured":"Vetter TR, Mascha EJ. Unadjusted bivariate two-group comparisons: when simpler is better. Anesth Analg. 2018;126(1):338\u201342.","journal-title":"Anesth Analg"},{"issue":"7","key":"3109_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"20","key":"3109_CR47","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1161\/CIRCULATIONAHA.120.046789","volume":"142","author":"N Xia","year":"2020","unstructured":"Xia N, Lu Y, Gu M, Li N, Liu M, Jiao J, et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction. Circulation. 2020;142(20):1956\u201373.","journal-title":"Circulation"},{"key":"3109_CR48","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3389\/fimmu.2019.02795","volume":"10","author":"CJ Albany","year":"2019","unstructured":"Albany CJ, Trevelin SC, Giganti G, Lombardi G, Scotta C. Getting to the heart of the matter: the role of regulatory T-cells (Tregs) in cardiovascular disease (CVD) and atherosclerosis. Front Immunol. 2019;10:2795.","journal-title":"Front Immunol"},{"issue":"14","key":"3109_CR49","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.7150\/thno.33112","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Duan Y, Sluijter JP, Xiao J. Lymphocytic subsets play distinct roles in heart diseases. Theranostics. 2019;9(14):4030\u201346.","journal-title":"Theranostics"},{"issue":"10","key":"3109_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1042\/CS20140672","volume":"128","author":"N Xia","year":"2015","unstructured":"Xia N, Jiao J, Tang TT, Lv BJ, Lu YZ, Wang KJ, et al. Activated regulatory T-cells attenuate myocardial ischaemia\/reperfusion injury through a CD39-dependent mechanism. Clin Sci (Lond). 2015;128(10):679\u201393.","journal-title":"Clin Sci (Lond)"},{"issue":"10","key":"3109_CR51","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/01.RES.0000249405.13536.49","volume":"99","author":"SA Huber","year":"2006","unstructured":"Huber SA, Feldman AM, Sartini D. Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice. Circ Res. 2006;99(10):1109\u201316.","journal-title":"Circ Res"},{"issue":"1","key":"3109_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather J, Hofmann UD, Beyersdorf N, Ramos GC, Vogel B, Frey A, Ertl G, Kerkau T, Frantz S. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ Res. 2014;115(1):55\u201367.","journal-title":"Circ Res"},{"issue":"6","key":"3109_CR53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1536\/ihj.52.382","volume":"52","author":"K Matsumoto","year":"2011","unstructured":"Matsumoto K, Ogawa M, Suzuki J-i, Hirata Y, Nagai R, Isobe M. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int Heart J. 2011;52(6):382\u20137.","journal-title":"Int Heart J"},{"issue":"8","key":"3109_CR54","doi-asserted-by":"publisher","first-page":"H1233","DOI":"10.1152\/ajpheart.00328.2014","volume":"307","author":"A Saxena","year":"2014","unstructured":"Saxena A, Dobaczewski M, Rai V, Haque Z, Chen W, Li N, Frangogiannis NG. Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function. Am J Physiol Heart Circ Physiol. 2014;307(8):H1233-1242.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4\u20135","key":"3109_CR55","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000303050","volume":"25","author":"T-T Tang","year":"2010","unstructured":"Tang T-T, Ding Y-J, Liao Y-H, Yu X, Xiao H, Xie J-J, et al. Defective circulating CD4+ CD25+ Foxp3+ CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem. 2010;25(4\u20135):451\u20138.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"3109_CR56","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2567.2005.02168.x","volume":"115","author":"RA Kemp","year":"2005","unstructured":"Kemp RA, Backstrom BT, Ronchese F. The phenotype of type 1 and type 2 CD8+ T cells activated in vitro is affected by culture conditions and correlates with effector activity. Immunology. 2005;115(3):315\u201324.","journal-title":"Immunology"},{"issue":"3","key":"3109_CR57","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.jaci.2014.11.001","volume":"135","author":"F Annunziato","year":"2015","unstructured":"Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626\u201335.","journal-title":"J Allergy Clin Immunol"},{"key":"3109_CR58","first-page":"17","volume":"8","author":"F Annunziato","year":"2014","unstructured":"Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Human Th1 dichotomy: origin, phenotype and biologic activities. Immunology. 2014;8:17.","journal-title":"Immunology"},{"issue":"6","key":"3109_CR59","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","volume":"182","author":"H Hamada","year":"2009","unstructured":"Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009;182(6):3469\u201381.","journal-title":"J Immunol"},{"issue":"11A","key":"3109_CR60","first-page":"C6","volume":"95","author":"G Torre-Amione","year":"2005","unstructured":"Torre-Amione G. Immune activation in chronic heart failure. Am J Cardiol. 2005;95(11A):C6\u2013C6 (discussion 38C-40C).","journal-title":"Am J Cardiol"},{"key":"3109_CR61","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2014.03.017","volume":"40","author":"C Brouwers","year":"2014","unstructured":"Brouwers C, Versteeg H, Meine M, Heijnen CJ, Kavelaars AM, Pedersen SS, Mommersteeg PM. Association between brain natriuretic peptide, markers of inflammation and the objective and subjective response to cardiac resynchronization therapy. Brain Behav Immun. 2014;40:211\u20138.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3109_CR62","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cardfail.2006.11.013","volume":"13","author":"A Michelucci","year":"2007","unstructured":"Michelucci A, Ricciardi G, Sofi F, Gori AM, Pirolo F, Pieragnoli P, et al. Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy. J Card Fail. 2007;13(3):207\u201310.","journal-title":"J Card Fail"},{"issue":"7","key":"3109_CR63","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1540-8159.2006.00430.x","volume":"29","author":"KT Lappeg\u00c5Rd","year":"2006","unstructured":"Lappeg\u00c5Rd KT, Bj\u00f8rnstad H. Anti-inflammatory effect of cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2006;29(7):753\u20138.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"3","key":"3109_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/sji.12328","volume":"82","author":"KT Lappegard","year":"2015","unstructured":"Lappegard KT, Bjornstad H, Mollnes TE, Hovland A. Effect of cardiac resynchronization therapy on inflammation in congestive heart failure: a review. Scand J Immunol. 2015;82(3):191\u20138.","journal-title":"Scand J Immunol"},{"issue":"4","key":"3109_CR65","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.healun.2021.12.008","volume":"41","author":"J Gambardella","year":"2022","unstructured":"Gambardella J, Jankauskas SS, D\u2019Ascia SL, Sardu C, Matarese A, Minicucci F, Mone P, Santulli G. Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy. J Heart Lung Transpl. 2022;41(4):438\u201341.","journal-title":"J Heart Lung Transpl"},{"issue":"7","key":"3109_CR66","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.peptides.2006.02.010","volume":"27","author":"G Boriani","year":"2006","unstructured":"Boriani G, Regoli F, Saporito D, Martignani C, Toselli T, Biffi M, et al. Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: time courses and prediction of response. Peptides. 2006;27(7):1776\u201386.","journal-title":"Peptides"},{"issue":"6","key":"3109_CR67","first-page":"545","volume":"16","author":"R Tarquini","year":"2009","unstructured":"Tarquini R, Guerra CT, Porciani MC, Michelucci A, Padeletti M, Ricciardi G, Chiostri M, Jelic S, Padeletti L. Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure. Cardiol J. 2009;16(6):545\u201352.","journal-title":"Cardiol J"},{"key":"3109_CR68","doi-asserted-by":"publisher","first-page":"2164017","DOI":"10.1155\/2019\/2164017","volume":"2019","author":"D Strassheim","year":"2019","unstructured":"Strassheim D, Dempsey EC, Gerasimovskaya E, Stenmark K, Karoor V. Role of inflammatory cell subtypes in heart failure. J Immunol Res. 2019;2019:2164017.","journal-title":"J Immunol Res"},{"issue":"11","key":"3109_CR69","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","volume":"131","author":"RA Frieler","year":"2015","unstructured":"Frieler RA, Mortensen RM. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation. 2015;131(11):1019\u201330.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03109-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03109-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03109-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T11:05:59Z","timestamp":1676459159000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03109-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,15]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3109"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03109-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1899142\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,15]]},"assertion":[{"value":"26 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with 1964 Declaration of Helsinki. The study was approved by Ethics Committee of the Coimbra Hospital and University Centre, with approval number: HUC-14-10 (Coimbra University Hospitals).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the studied patients gave and signed the informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}